GLAND2,950.00

Gland Pharma Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABAUROPHARMAPPLPHARMASYNGENEWOCKPHARMAASTERDMCOHANCELALPATHLABMcap ₹48,604 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt319.8269.2243.4243.4
Net Debt-37.3-2,287.0-3,115.7-3,115.7
Total Debt/Equity0.040.030.020.02
Net Debt/Equity0.00-0.25-0.30-0.30
Total Debt/EBITDA0.240.210.150.15
Net Debt/EBITDA-0.03-1.80-1.91-1.78
Interest Coverage (EBIT/Interest)37.7321.2236.2436.24
Total Debt/Total Capital %3.542.862.302.30
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.